Search for: "Medtronic PLC" Results 41 - 46 of 46
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jan 2009, 7:02 am
One of the contributors to Yale Law School's Career Development Office employment guide for law students is a senior lawyer at Medtronic. [read post]
17 Oct 2008, 2:40 pm
(IP Dragon) Bad faith trade mark registrations: Sony Ericsson v Mr Lui (IPKat) In letter to Chinese government, Intellectual Property Owners Association (IPOA) weakens opposition to 'international exhaustion' (Hal Wegner) IP laws evolving in China (Law360)   Colombia Colombia changes trade name deposit requirements (IP tango) FINESSE, MEN'S FITNESS confusingly similar, rules Colombia Council (IP tango)   Denmark Court denies injunction request in colour trade… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
22 Feb 2008, 6:00 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
11 Jan 2008, 9:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]Highlights this week included: European Commission launches consultation on ‘Content Online in the Single Market': (IPKat), (Out-Law), (IPR Helpdesk), UK government launches consultation on copyright exceptions: (IPKat), (Michael Geist), (IMPACT), (Patry Copyright Blog), (Out-Law), (Ars Technica), (IP Law360), Cordis Corporation - US Court of Appeals… [read post]
26 Jun 2007, 7:00 am
Glaxo Wellcome PLC, 246 F.3d 934, 942-43 (7th Cir. 2001).Where these laws govern, third parties have a tough time prevailing against drug and device companies on consumer fraud or deceptive trade practice claims. [read post]